Interventional device developer Boston Scientific of Natick, MA, said it filed a mandatory notification with the European Commission (EC) of its intention to acquire all of the outstanding shares of Indianapolis-based Guidant.
Boston Scientific entered into an agreement with Abbott Laboratories under which Abbott will acquire Guidant's vascular intervention and endovascular businesses, while agreeing to share rights to Guidant's drug-eluting stent program with Boston Scientific. Boston Scientific said that it believes the agreement with Abbott will enable it to rapidly secure antitrust approvals for the proposed transaction from the EC.
Abbott's notification to the EC was made concurrently with Boston Scientific's, the company said.
By AuntMinnie.com staff writers
February 24, 2006
Related Reading
Boston Scientific shows 2005 sales gains, February 7, 2006
Boston Scientific raises Guidant offer, January 17, 2006
Abbott amends Boston Scientific agreement, January 17, 2006
Boston Scientific ups Guidant bid, January 13, 2006
Tobin extends term with Boston Scientific, January 5, 2006
Copyright © 2006 AuntMinnie.com
